Mounjaro will be made available on the NHS but the rollout will be phased, with only those with the highest need getting the jabs first
Mounjaro, made by US pharmaceutical company Eli Lilly, is vying for market share among a new class of drugs originally designed to treat diabetes which have been shown to aid dramatic weight loss. Millions of eligible patients must wait up to 12 years to get a new drug dubbed the “King Kong of weight-loss jabs” after officials decided the health service could only cope with a phased rollout.
It means the postcode lottery over NHS weight management services is likely to continue for several years – with local servicesthe firm recognised there is “significant unmet need and high demand” for weight-loss drugs and its goal is to “make our medicines accessible to people that need them”. The US-based firm said it continues to add manufacturing and supply capacity around the world to meet global demand, having invested more than $20bn since 2020.
Final draft guidance published by Nice shows NHS England requested that Mounjaro is rolled out over a period of 12 years. The watchdog recommends prioritising patients receiving care from specialist weight management services who will be able to access the drug within 90 days of the guidance being published on 23 December.
He said: “We look forward to working with NHS England to ensure we can best meet the current unmet need of people living with obesity and deliver on the Government’s obesity goals.”
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Missing person appeal for Belfast man seen 24-hours agoBrian was wearing NHS branded navy combat trousers, navy tank top and NHS branded navy jacket
Read more »
NHS warns high blood pressure patients to avoid common medicationThe NHS has issued a warning to people with certain health conditions, including high blood pressure, to avoid taking decongestants if they have a cold or the flu
Read more »
Labour's NHS reforms 'put elderly patients at risk of worse care'Frontline medics say 'naming and shaming' hospitals in league tables 'likely' to put vulnerable patients at greater risk
Read more »
NHS advises patients to 'choose the right service' amid 'extreme pressure'Familiarise yourself with different local services
Read more »
Drug costing chronic and recurrent UTI patients £500 a year set for NHS rollout'Game-changer' drug Hiprex is set to be approved for NHS use - but there is still no official guidance for treating chronic UTIs
Read more »
NHS Grampian ends 'critical incident' that saw patients sent to other hospitalsNHS Grampian announced a critical incident on Thursday evening.
Read more »